Herpes Labialis (Oral Herpes) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Herpes Labialis (Oral Herpes) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017" drug pipelines to their offering.

Herpes Labialis (Oral Herpes) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe.

A key objective of the Herpes Labialis (Oral Herpes) Report is to understand the market and pipeline status of the drugs around the Herpes Labialis (Oral Herpes) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline strategies. The Report provides the historical and forecasted sales of the drugs till 2018.

The Herpes Labialis (Oral Herpes) Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Herpes Labialis (Oral Herpes).

While the leading brands, companies and chemicals are considered thoroughly, the report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Key Topics Covered:

1. Indication Overview

2. Market Drugs Landscape

3. Global API Manufacturers Assessment

4. Phase III Drugs Landscape

5. Drugs Market Data and Forecasted Sales Figure-2018

6. Marketed Drugs for Herpes Labialis (Oral Herpes)

7. Phase III Drugs for Herpes Labialis (Oral Herpes)

8. Discontinued Drugs for Herpes Labialis (Oral Herpes)

9. Appendix

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/bj5p45/herpes_labialis

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs, Sexual and Reproductive Health Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Diseases Drugs, Sexual and Reproductive Health Drugs